The results presented in two preceding papers in this series (9, 10) provided evidence that both arginyl-transfer ribonucleic acid (tRNA) synthetase and arginyl-tRNA may be involved in repression control of arginine biosynthesis.
To address the question of arginyl-tRNA synthetase involvement in repression by an alternative method, a correlation was made between inhibition of this enzyme activity and repression of synthesis of the arginine biosynthetic enzymes. We previously reported evidence for the in vitro inhibition of arginyl-tRNA synthetase activity of Escherichia coli by three arginine biosynthetic intermediates (ornithine, citrulline, and argininosuccinate) (12) . Similar results have been reported by Nazario for this activity in Neurospora crassa (5) , and by Sussenbach and Strijkert (8) . However, in Chlamydomonas reinhardi the physiological significance of these observations in E. coli strains is not understood.
In this paper, we report evidence which suggests that the in vivo accumulation of omithine, citrulline, and argininosuccinate in arginine auxotrophs caused inhibition of arginyl-tRNA synthetase activity. Furthermore, we provide evidence which suggests that inhibition of this enzyme activity was accompanied by a derepression of synthesis of the arginine biosynthetic enzymes.
MATERIALS AND METHODS
The organisms used in this study are listed in Table 1 . Media and methods of cultivation were the same as previously described (9, 10) , except that the continuous culture experiments (chemostats) were performed with amino acid limitations as indicated.
Preparation of cell extract was as described previously (2) .
Omithine transcarbamylase and aminoacyl-tRNA synthetase activities were determined by the methods already described (9, 10) . Specific activity is expressed as units of enzyme per milligram of protein.
Protein determination was by the procedures of Lowry et al. (3) .
Inhibition studies were performed by the [4C ]amino acid attachment assay as described previously (12) , except that the inhibitor (1 M) Diethylaminoethyl (DEAE)-cellulose and hydroxylapatite column chromatography was performed as previously described (9, 10).
Extracts were assayed for ornithine (1, 4) , citrulline (4), and argininosuccinate (4) by previously described methods.
Labeled amino acids and tRNA were obtained from the New England Nuclear Corp., and General Biochemical Co., respectively. N-acetyl glutamic acid, N-acetyl-omithine, L-ornithine, L-citrulline, and Larginine were obtained from Sigma Chemical Co.
RESULTS
Inhibition of arginyl-tRNA synthetase activity. In a previous report (12) , we presented evidence for inhibition of arginyl-tRNA synthetase activity by the arginine precursors ornithine, citrulline, and argininosuccinate in extracts of one strain (AB1132) of E. coli. A similar inhibition study was performed using 
NP74
Arginine auxotroph lacking argininosuccinase activity and derived from strain NP7, repressible synthesis of arginine a Strains NP2, NP7, NP71, NP73, and NP74 were obtained from the collection of F. C. Neidhardt, strain AB1132 was obtained from E. A. Adelberg, and strain HP1802 was isolated as previously described (11) .
extracts from strains AB1132, NP2, and NP7 (Table 2 ). In a reaction mixture containing 1 AM arginine precursor and 20 ,M L-arginine, the attachment of L-["4Clarginine to tRNA was inhibited by about 40% by both ornithine and argininosuccinate (Table 2 ). These inhibitors were equally effective with extracts of either strain, which makes unlikely any influence of strain specificity on the character of the results (Table 2) .
Citrulline was only abput one-half as potent an inhibitor as were omithine and argininosuccinate. However, if the reaction mixtures containing the inhibitors were incubated at room temperature for 5 min before the addition of L-arginine, the amount of inhibition by citrulline was increased about 75% for extracts of each strain (Table 2) . Nevertheless, we considered the possibility that other components in the crude extract could have influenced these results. Therefore, the same inhibition experiments were performed with extracts of strain NP2 as a function of activity enhancement (purification steps) over that of the crude extract (Table 3 ). We found that (i) the inhibition by these arginine precursors of this enzyme activity in the crude extract is comparable to that presented in Table  2 for strain NP2 (Table 3) ; (ii) analysis of the supernatant fluid (after dialysis) of a 35% ammonium sulfate fractionation of a 6% streptomycin supernatant fluid revealed a pattern of inhibition similar to that observed for the crude extract (Table 3) ; (iii) the amount of inhibition of arginyl-tRNA synthetase activity by ornithine and citrulline was increased, however, when determined by using the pooled fractions from a DEAE-cellulose column (Table 3) ; and (iv) the inhibition of this enzyme activity in the pooled fractions from the hydroxylapatite column was increased about 70% for ornithine, 100% for citrulline, and 90% for argininosuccinate over that observed using the crude extract (Table 3 ). These data suggest that the inhibition of arginyl-tRNA synthetase activity was not positively influenced by nucleic acids, un- related proteins, and other components in the crude extracts. Therefore, arginyl-tRNA synthetase activity is inhibited by these arginine biosynthetic precursors in vitro. Because of these results, it was of interest to determine whether this enzyme activity was affected by the endogenous accumulation of these precursors.
To address the question of in vivo inhibition of arginyl-tRNA synthetase activity by the endogenous accumulation of arginine biosynthetic precursors, we made use of four arginine auxotrophs with the blocked enzymatic steps being at different positions in the arginine pathway. These auxotrophs are isogenic strains and were derived from E. coli W strain NP7 (Table 1) . A schematic presentation of the arginine biosynthetic pathway showing the various intermediates and enzymes acting at each step is shown in Fig. 1 . For these four arginine auxotrophs, strain NP71 is blocked at enzymatic step 1, strain NP72 is blocked at enzymatic step 5, strain NP73 is blocked at enzymatic step 6, and strain NP74 is blocked at enzymatic step 8 ( Fig. 1) . Therefore, during arginine starvation these auxotrophs would presumably accumulate glutamate, acetylornithine, ornithine, and argininosuccinate, respectively ( Fig. 1) . Before initiation of the inhibition experiment, it was deemed essential to establish whether these were tight arginine auxotrophs or bradytrophs, and to determine the concentration of L-arginine and time units in order to achieve a period of normal growth before arginine starvation. Each auxotroph grew at the normal rate in minimal medium supplemented with L-arginine at 100 Ag/ml (Fig. 2) . A similar pattern of growth was obtained with minimal medium supplemented with acetylglutamate (150 ,g/ ml) for strain NP71, ornithine (100 ,ug/ml) for strain NP72, citrulline (100 MAg/ml) for strain NP73, and arginine (100 Mg/ml) for strain NP74. Conversely, after a period of essentially normal growth, each auxotrophic culture showed no further increase in mass after the exhaustion of L-arginine (Fig. 3) , whereas, as expected, the normal strain maintained the normal growth rate. Therefore, these data ( Fig.  2 and 3 ) indicate that these strains are strict arginine auxotrophs and that they exhibit growth responses consistent with the site of the enzymatic block in the arginine pathway.
Activity of arginyl-tRNA synthetase in extracts of arginine auxotrophs starved of arginine. The four arginine auxotrophs blocked at different steps in the arginine pathway were grown in unrestricted arginine medium, collected by centrifugation, washed twice with minimal medium, and incubated with 2 jg of L-arginine per ml. After growth had terminated because of the exhaustion of arginine, the cells were further incubated for 1 h and the extracts were assayed for arginyl-tRNA synthetase activity. These results (Table 4) indicate that the extracts of auxotrophs which had presumably accumulated ornithine and argininosuccinate had only about 40% of the activity of the wild-type strain. There was also a decrease in activity in extracts of the cultures in which acetylornithine and glutamate had presumably accumulated in vivo. Upon dialysis of these extracts, the activity was increased to nearly the normal level (Table 4) . In contrast, the activity of leucyl-tRNA synthetase was essentially the same in all extracts (nondialyzed and dialyzed) of these arginine-starved cultures ( Table 4) . The results of estimation of the amount of ornithine, citrulline, and argininosuccinate in these extracts suggest that the predicted intermediates had accumulated in these cultures (Table 5) . While other explanations are not completely ruled out, these results are consistent with inhibition of arginyltRNA synthetase by these precursors as ob- NP71, A; NP72, 0; NP73, 0; and NP74, A. served in an in vitro assay system. In view of the findings of previous reports from our laboratory (9, 10) , the level of the arginine precursors, which inhibit arginyl-tRNA synthetase activity, may be important in the control of arginine biosynthesis.
Level of ornithine transcarbamylase (OTC). The same arginine auxotrophs were starved of arginine, and OTC activity in extracts of these four cultures was determined. The highest level of OTC activity was attained in the auxotroph which accumulated ar- gininosuccinate, whereas the accumulation of glutamate and acetylornithine had the least effect on OTC level (Table 6 ). Furthermore, the addition of excess ornithine to the arginine auxotroph blocked between acetylornithine and ornithine grown with restricting amounts of L-arginine (2.5 ug/ml) caused a significant increase in the level of OTC (Table 7) . Further, an increase in OTC level is seen when argininosuccinate was added to an arginine-restricted culture of an auxotroph blocked between argininosuccinate and arginine (Table 7) . There was a small, possibly significant increase in the OTC level in extracts of the appropriate auxotroph to which acetylglutamate was added (Table 7) . These results suggest that ornithine and argininosuccinate, which inhibit arginyltRNA synthetase activity, caused a further derepression of OTC synthesis in these cultures. It should be noted that OTC was repressed in each auxotroph during growth in excess L-argi- a After 2 h of incubation during arginine starvation, the cells were collected by centrifugation, sonically treated, and centrifuged at 12,500 rpm for 20 min at 4 C. The supernatant fluid was collected, treated with 5% trichloroacetic acid to precipitate proteins, and centrifuged at 15,000 rpm for 20 min at 4 C. Samples (1 ml) of the extract were assayed for the arginine precursors as indicated in Materials and Methods.
b Amounts expressed as micromoles per milligram of protein.
nine. However, the addition of excess amounts of the precursors did not always restore the wild-type growth rate, which probably reflects the efficiency with which these compounds entered the cells. The lack of a stimulation of growth for the arginine-restricted culture to which argininosuccinate was added is consistent with the site of the enzymatic block in the pathway for this mutant. However, a comparison of the growth rates and OTC levels for the acetylglutamate-and ornithine-supplemented cultures suggests that the significant increase in OTC activity was specifically related to ornithine supply of the cells (Table 7 ). An altemative study of the possible correlation between OTC activity and the arginine precursors was examined by continuous culture methods. These auxotrophs were grown in a chemostat with limited arginine in one experiment and with a specific arginine precursor in another ( Table 8 ). The results indicate that the level of OTC is highest in an arginine-limited chemostat culture of the mutant, which presumably accumulated argininosuccinate. Also, growth of strain NP72 (blocked between acetylornithine and ornithine) with limited omithine was accompanied by further derepression of OTC synthesis over that observed during arginine-limited growth of this strain (Table 8) . A similar result is observed for strain NP74 (blocked between argininosuccinate and arginine) during arginine-and argininosuccinatelimited growth as compared with that for arginine-limited growth of this auxotroph (Table 8) . Strain HP1802, an arginine auxotroph blocked at the N-acetyl-glutamyl kinase step (enzyme no. 2), was grown for 14 h at a k (specific growth rate constant) of 0.40 in an argininelimited chemostat (5 ug/ml) as described by Williams and Neidhardt (11) . At zero time, the specific activity of OTC in extracts of the arginine-restricted culture was 260 enzyme units per milligram of protein. To each of five different chemostat cultures, 100 ,ug of arginine (or one of the arginine precursors) per ml was added at zero time. Samples were collected from each culture after 90 min of unrestricted growth, and OTC activity (units per milligram of protein) with the following compounds added, was determined to be: arginine, 60; acetylornithine, 95; ornithine, 135; citrulline, 90, and argininosuccinate, 105. These results clearly indicate that excess ornithine and argininosuccinate were least effective in repressing OTC synthesis in this strain. DISCUSSION The data presented in this paper strengthen our previous findings (9) that the arginine precursors ornithine, citrulline, and argininosuccinate, inhibit arginyl-tRNA synthetase activity in the in vitro assay. Similar results were obtained by Nazario (5) As reported for the Neurospora (5) and Chlamydomonas (8) systems, the data presented in this report suggest that arginyl-tRNA synthetase activity was inhibited in cells which endogenously accumulated omithine, citrulline, and argininosuccinate. Is this apparent in vivo inhibition of arginyl-tRNA synthetase activity physiologically significant? The data on OTC levels in these cells suggest a direct correlation between derepression of arginine biosynthesis and inhibition of the synthetase activity. This contention is supported by the following observations: (i) ornithine and argininosuccinate were the most effective inhibitors of this synthetase activity in vitro; (ii) synthesis of OTC was derepressed to the greatest extent in cells in which ornithine was accumulated endogenously In previous reports (9, 10), we have presented evidence that arginyl-tRNA synthetase and arginyl-tRNA may be essential for repression control of arginine biosynthesis. The data in the present report strengthen those results and clearly suggest that inhibition of arginyl-tRNA synthetase is accompanied by a derepression of arginine biosynthesis.
